1. Editorial Board. (October 2015) Journal: Pulmonary pharmacology & therapeutics Issue: Volume 34(2015:Oct.) Page Start: IFC Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials. (October 2015) Authors: Zhang, Liang; Cao, Hong-Yi; Zhao, Shuang; Yuan, Li-Jie; Han, Dan; Jiang, Hong; Wu, Song; Wu, Hong-Min Journal: Pulmonary pharmacology & therapeutics Issue: Volume 34(2015:Oct.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Editorial Board. (August 2016) Journal: Pulmonary pharmacology & therapeutics Issue: Volume 39(2016:Aug.) Page Start: IFC Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes. (August 2019) Authors: Poller, Birk; Woessner, Ralph; Barve, Avantika; Tillmann, Hanns-Christian; Vemula, Janardhana; Nica, Alexandra; Elbast, Walid; Schiller, Hilmar; End, Peter; Camenisch, Gian; Weiss, Markus Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials. (August 2019) Authors: Donohue, James F.; Feldman, Gregory; Sethi, Sanjay; Barnes, Chris N.; Pendyala, Srikanth; Bourdet, David; Crater, Glenn Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Airway hypersensitivity induced by eosinophil granule-derived cationic proteins. (August 2019) Authors: Lee, Lu-Yuan; Gu, Qihai; Lin, An-Hsuan; Khosravi, Mehdi; Gleich, Gerald Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Editorial Board. (August 2019) Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics of ambrisentan in a patient with Pulmonary Arterial Hypertension and a total gastrectomy. (August 2019) Authors: Abston, Eric; Farber, Harrison W. Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials. (August 2019) Authors: Ray, Riju; Tombs, Lee; Naya, Ian; Compton, Chris; Lipson, David A.; Boucot, Isabelle Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Are neural pathways processing airway inputs sensitized in patients with cough hypersensitivity?. (August 2019) Authors: Farrell, Michael J.; Mazzone, Stuart B. Journal: Pulmonary pharmacology & therapeutics Issue: Volume 57(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗